<?xml version="1.0" encoding="UTF-8"?>
<p id="p0515">In 1988, Yamagishi et al. described the isolation of two triterpene acids from 
 <italic>Hyptis capitata</italic> with significant 
 <italic>in vitro</italic> action in human colon tumor cells (HCT-8), hyptatic acid A (
 <bold>90</bold>) (ED
 <sub>50</sub> 4.2 μg/mL) and 2
 <italic>α</italic>-hydroxyursolic acid (
 <bold>86</bold>) (ED
 <sub>50</sub> 2.7 μg/mL). In the same way, lignans isolated from 
 <italic>Condea verticillata</italic> (syn. 
 <italic>Hyptis verticillata</italic>) were assayed for the cytotoxic activity on lymphocytic leukemia system (P-388). The compounds 4′-demethyldeoxypodophyllotoxin (
 <bold>114</bold>) (ED
 <sub>50</sub> 0.005 μg/mL), 5-methoxydehydropodophyllotoxin (
 <bold>116</bold>) (ED
 <sub>50</sub> 4 μg/mL), dehydro-
 <italic>β</italic>-peltatin-methyl ether (
 <bold>117</bold>) (ED
 <sub>50</sub> 1.8 μg/mL), yatein (ED
 <sub>50</sub> 0.4 μg/mL) (
 <bold>120</bold>), deoxypicropodophyllin (
 <bold>122</bold>) (ED
 <sub>50</sub> 0.1 μg/mL), and 
 <italic>β</italic>-apopicropodophyllin (
 <bold>123</bold>) (ED
 <sub>50</sub> 0.002 μg/mL) demonstrated significant cytotoxic activity (
 <xref rid="bib186" ref-type="bibr">Novelo et al., 1993</xref>). It is important to highlight that podophyllotoxin derivatives, such as etoposide, have been used for decades to treat various types of cancer (
 <xref rid="bib242" ref-type="bibr">Stähelin and von Wartburg, 1991</xref>; 
 <xref rid="bib183" ref-type="bibr">Newman and Cragg, 2020</xref>).
</p>
